Concurrent Management of Prostate Cancer and Perianal Fistula: A Case Report, Treatment Considerations, and Review of Literature.

Authors

Kwabena Boahen Asare, Lorraine Zaki, Bassem Zaki

Published in

Case reports in urology. Volume 2026. Pages 9964573. Epub Aug 21, 2026.

Abstract

Prostate cancer and pre-existing perianal fistula are challenging conditions to manage concurrently as pelvic radiotherapy may raise concern for impaired wound healing, infection, or fistula progression. Although radiotherapy has traditionally raised concern as a risk factor for fistulization, this case suggests that selected patients with a pre-existing perianal fistula may be treated with careful multidisciplinary planning and modern radiotherapy techniques.
A 70-year-old male diagnosed with favorable intermediate-risk prostate cancer and a concurrent perianal fistula was treated with definitive radiation therapy and staged surgical treatment, respectively. The patient underwent intensity-modulated radiation therapy (IMRT) with daily image-guided radiation therapy (IGRT), receiving a total dose of 70 Gy in 28 fractions while minimizing radiation dose to the perianal region. Prior to radiation, a seton was placed to facilitate drainage and reduce infection risk from the fistula. Following radiotherapy, the patient underwent successful surgical fistulectomy without complications. At 26 months posttreatment, the patient remains free of biochemical recurrence and without recurrence of the perianal fistula.
This case highlights the clinical importance of applying and coordinating established management principles to an uncommon and challenging scenario. Although seton placement, IMRT/IGRT, and fistula surgery are individually well-established approaches, their sequencing in the setting of localized prostate cancer with a concurrent pre-existing perianal fistula remains poorly described. This report offers a practical example of individualized, staged management in a complex clinical scenario for which standardized treatment pathways remain limited.

PMID:
42633054
Bibliographic data and abstract were imported from PubMed on 23 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.